Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218

ras oncogenes in human cancer: a review.

Bos, J. L. (1989) · PubMed · Cited by 5,061

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927

RAS oncogenes: the first 30 years

Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566

Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras

Guo, X., Schrader, K. A., Xu, Y., & Schrader, J. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208441 · Cited by 23

Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis

Hossain, M. M., Nakayama, K., Shanta, K., Razia, S., Ishikawa, M., Ishibashi, T., Yamashita, H., Sato, S., Iida, K., Kanno, K., et al. (2021) · Cancers · doi:10.3390/cancers13133174 · Cited by 20

An introduction to molecular targeted therapy of cancer

Allgayer, H., & Fulda, S. (2008) · Advances in Medical Sciences · doi:10.2478/v10039-008-0025-9 · Cited by 20

Using Sensors and Generators of H 2 O 2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate

Huang, B. K., Langford, T. F., & Sikes, H. D. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6482 · Cited by 20

Uncoupling Oncogene-Induced Senescence (OIS) and DNA Damage Response (DDR) triggered by DNA hyper-replication: lessons from primary mouse embryo astrocytes (MEA)

Seoane, M., Costoya, J. A., & Arce, V. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13408-x · Cited by 20

Future of Early Detection of Lung Cancer: The Role of Mouse Models

Shaw, A. T., Kirsch, D. G., & Jacks, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-9005 · Cited by 20

Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma

Fiorino, S., Lorenzini, S., Masetti, M., Deleonardi, G., Grondona, A. G., Silvestri, T., Chili, E., Prete, P. D., Reggiani, M. L. B., Cuppini, A., et al. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.008 · Cited by 19

Clinical trials of vaccines for immunotherapy in pancreatic cancer

PLATE, J. M. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.77 · Cited by 19

Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities

Zhang, J., Park, D., Shin, D. M., & Deng, X. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv118 · Cited by 20

Overexpression of Fgfr2c causes craniofacial bone hypoplasia and ameliorates craniosynostosis in the Crouzon mouse

Lee, K. K. L., Peskett, E., Quinn, C. M., Aiello, R., Adeeva, L., MOULDING, D. A., Stanier, P., & Pauws, E. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035311 · Cited by 19

NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma

Ramakrishnan, G., Parajuli, P., Singh, P., Friend, C., Hurwitz, E. G., Prunier, C., Razzaque, M. S., Xu, K., & Atfi, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111623 · Cited by 19

Wash‐free fluorescent tools based on organic molecules: Design principles and biomedical applications

Tan, J., Wang, C., Hu, Z., & Zhang, X. (2024) · Exploration · doi:10.1002/exp.20230094 · Cited by 19

BAC Consensus Conference, November 4???6, 2004: Epidemiology, Pathogenesis, and Preclinical Models

Christiani, D. C., Pao, W. J., DeMartini, J. C., Linnoila, R. I., Malkinson, A. M., Onn, A., Politi, K. A., Sharp, M. C., & Kim, K. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30002-2 · Cited by 19

Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise

Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 20

Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer

Sun, T., Peng, H., Mao, W., Ma, L., Liu, H., Mai, J., & Jiao, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61795 · Cited by 18

Multi-apical polarity of alveolar stem cells and their dynamics during lung development and regeneration

Konkimalla, A., Konishi, S., Kobayashi, Y., Murthy, P. K. L., Macadlo, L., Mukherjee, A., Elmore, Z. C., Kim, S., Pendergast, A. M., Lee, P. J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105114 · Cited by 19

Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras

Velho, S., & Haigis, K. M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.06.002 · Cited by 18

Cre/loxP‐regulated transgenic zebrafish model for neural progenitor‐specific oncogenic Kras expression

Seok, S. H., Na, Y., Han, J., Kim, T., Jung, H. M., Lee, B., Emelyanov, A., Parinov, S., & Park, J. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01393.x · Cited by 19

Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

Forton, D. M. (2006) · Gut · doi:10.1136/gut.2006.100081 · Cited by 18

Oncogenic K-Ras suppresses global miRNA function

Shui, B., Beyett, T. S., Chen, Z., Li, X., Rocca, G. L., Gazlay, W., Eck, M. J., Lau, K. S., Ventura, A., & Haigis, K. M. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.008 · Cited by 17

Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma

Zhao, T., Jiang, T., Li, X., Chang, S., Sun, Q., Kong, F., Kong, X., Wei, F., He, J., Hao, J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1143 · Cited by 17

Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia

Yang, X., Rosa, F. G. L., Genova, E. E., Huber, K. M., Schaack, J. B., DeGregori, J. V., Serkova, N. J., Li, Y., Su, L., Kessler, E. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074809 · Cited by 17

Importance of the type I insulin-like growth factor receptor inHER2, FGFR2andMET-unamplified gastric cancer with and without Ras pathway activation

Saisana, M., Griffin, S. M., & May, F. E. B. (2016) · Oncotarget · doi:10.18632/oncotarget.10642 · Cited by 17

N-Acetylcysteine Reduces the Pro-Oxidant and Inflammatory Responses during Pancreatitis and Pancreas Tumorigenesis

Minati, M.-A., Libert, M., Dahou, H., Jacquemin, P., & Assi, M. (2021) · Antioxidants · doi:10.3390/antiox10071107 · Cited by 17

PLC-γ and PI3K Link Cytokines to ERK Activation in Hematopoietic Cells with Normal and OncogenicKras

Díaz-Flores, E., Goldschmidt, H. L., Depeille, P., Ng, V., Akutagawa, J., Krisman, K., Crone, M., Burgess, M. R., Williams, O., Houseman, B. T., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004125 · Cited by 17

The role of oncogenic Ras in human skin tumorigenesis depends on the clonogenic potential of the founding keratinocytes

Maurelli, R., Tinaburri, L., Gangi, F. M., Bondanza, S., Severi, A. L., Scarponi, C., Albanesi, C., Mesiti, G., Guerra, L., Capogrossi, M. C., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.176842 · Cited by 17

Satellite RNA Increases DNA Damage and Accelerates Tumor Formation in Mouse Models of Pancreatic Cancer

Kishikawa, T., Otsuka, M., Suzuki, T., Seimiya, T., Sekiba, K., Ishibashi, R., Tanaka, E., Ohno, M., Yamagami, M., & Koike, K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0139 · Cited by 17

Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice

Zandvakili, I., Davis, A. K., Hu, G., & Zheng, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127923 · Cited by 17

K‐RasV14I‐induced Noonan syndrome predisposes to tumour development in mice

Hernández‐Porras, I., Schuhmacher, A. J., Garcia‐Medina, R., Jiménez, B., Cañamero, M., de Martino, A., & Guerra, C. (2016) · The Journal of Pathology · doi:10.1002/path.4719 · Cited by 16

Allosteric Regulation of Switch-II Domain Controls KRAS Oncogenicity

Yang, M. H., Tran, T. H., Hunt, B., Agnor, R., Johnson, C. W., Shui, B., Waybright, T. J., Nowak, J. A., Stephen, A. G., Simanshu, D. K., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3210 · Cited by 16

Activated N-Ras signaling regulates arterial-venous specification in zebrafish

Ren, C., Wang, L., Jia, X., Liu, Y., Dong, Z., Jin, Y., Chen, Y., Deng, M., Zhou, Y., Zhou, Y., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-34 · Cited by 16

The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling

Tetley, G. J. N., Murphy, N. P., Bonetto, S., Ivanova, G. D., Revell, J. D., Mott, H. R., Cooley, R., & Owen, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010077 · Cited by 16

Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice

Erener, S., Ellis, C. E., Ramzy, A., Glavas, M. M., O’Dwyer, S. M., Pereira, S., Wang, T., Pang, J., Bruin, J. E., Riedel, M. J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100434 · Cited by 16

Molecular mechanisms of cellular senescence and immortalization of human cells

Kiyono, T. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.12.1623 · Cited by 16

HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer

Veite-Schmahl, M. J., Joesten, W. C., & Kennedy, M. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.216 · Cited by 16

Adenoviral vectors transduce alveolar macrophages in lung cancer models

Tippimanchai, D., Nolan, K., Poczobutt, J. M., Verzosa, G., Li, H. Y., Scarborough, H. A., Huang, J., Young, C. D., DeGregori, J. V., Nemenoff, R. A., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1438105 · Cited by 16

Biological and clinical implications of early-onset cancers: A unique subtype

He, T., Li, J., Xu, Z., Chen, Q., Yin, H., Pu, N., Wang, W., & Liu, L. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104120 · Cited by 15

Conditional Expression of Oncogenic C-RAF in Mouse Pulmonary Epithelial Cells Reveals Differential Tumorigenesis and Induction of Autophagy Leading to Tumor Regression

Ceteci, F., Xu, J., Ceteci, S., Zanucco, E., Thakur, C., & Rapp, U. R. (2011) · Neoplasia · doi:10.1593/neo.11652 · Cited by 16

Rapamycin impairs UV induction of mutant‐p53 overexpressing cell clusters without affecting tumor onset

Voskamp, P., Bodmann, C. A., Rebel, H. G., Koehl, G. E., Tensen, C. P., Bavinck, J. N. B., Ghalbzouri, A. E., van Kranen, H. J., Willemze, R., Geissler, E. K., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27391 · Cited by 15

Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis

Novitskiy, S. V., Zaynagetdinov, R., Vasiukov, G., Gutor, S. S., Han, W., Serezani, A. P. M., Matafonov, A., Gleaves, L. A., Sherrill, T. P., Polosukhin, V. V., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.27345 · Cited by 15

Senescence in RASopathies, a possible novel contributor to a complex pathophenoype

Engler, M., Fidan, M., Nandi, S., & Cirstea, I. C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111411 · Cited by 15

Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas

Smith, J. P., Cao, H., Edmondson, E. F., Dasa, S. S. K., & Stern, S. T. (2021) · Biomolecules · doi:10.3390/biom11121766 · Cited by 15

EP4 upregulation of Ras signaling and feedback regulation of Ras in human colon tissues and cancer cells

Wu, C., Shih, Y., Chang, C.-H., Ou, T., Huang, C., Hsu, J., & Wang, C. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0562-4 · Cited by 15

Spontaneous transformation of a clonal population of dermis-derived multipotent cells in culture

Shi, C., Mai, Y., Zhu, Y. J., Cheng, T., & Su, Y. (2007) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-007-9056-y · Cited by 15

Generation of Mouse for Conditional Expression of Forkhead Box A2

Wang, P., Wu, S., Brooks, K. E., Kelleher, A. M., Milano-Foster, J., DeMayo, F. J., & Spencer, T. E. (2018) · Endocrinology · doi:10.1210/en.2018-00158 · Cited by 15

Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation

Algül, H., Wagner, M., Lesina, M., & Schmid, R. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22779 · Cited by 15

A DNA transposon-based approach to validate oncogenic mutations in the mouse

Su, Q., Prosser, H. M., Campos, L. S., Ortiz, M., Nakamura, T., Warren, M. V., Dupuy, A. J., Jenkins, N. A., Copeland, N. G., Bradley, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807785105 · Cited by 15

Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette

Wang, W. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i13.2026 · Cited by 15

Correction: Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas

Vincent, D. F., Yan, K.-P., Treilleux, I., Gay, F., Arfi, V., Kaniewski, B., Marie, J. C., Lépinasse, F., Martel, S., Goddard‐Léon, S., et al. (2009) · PLoS Genetics · doi:10.1371/annotation/7941c465-532f-4b42-b541-72d0810943b9 · Cited by 15

DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.

Jimenez, T., Barrios, A., Tucker, A., Collazo, J., Arias, N., Fazel, S., Baker, M., Halim, M., Huynh, T., Singh, R., et al. (2020) · PubMed Central · Cited by 14

Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells

Dahou, H., Minati, M.-A., Jacquemin, P., & Assi, M. (2021) · Antioxidants · doi:10.3390/antiox10040570 · Cited by 14

Alternative polyadenylation is a determinant of oncogenic Ras function

Subramanian, A., Hall, M., Hou, H., Mufteev, M., Yu, B., Yuki, K. E., Nishimura, H., Sathaseevan, A., Lant, B., Zhai, B., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh0562 · Cited by 15

KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma

Fu, T., Guzzetta, A. A., Jeschke, J., Vatapalli, R. J., Dave, P., Hooker, C. M., Morgan, R., Iacobuzio–Donahue, C. A., Liu, B., & Ahuja, N. (2012) · International Journal of Cancer · doi:10.1002/ijc.27910 · Cited by 14

Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer

Hurwitz, E. G., Parajuli, P., Ozkan, S., Prunier, C., Nguyen, T. L., Campbell, D. J. W., Friend, C., Bryan, A., Lu, T.-X., Smith, S. C., et al. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202203036 · Cited by 13

Signal transduction pathways participating in homeostasis and malignant transformation of the intestinal tissue

Krausová, M., & Kořínek, V. (2012) · Neoplasma · doi:10.4149/neo_2012_090 · Cited by 13

Comparison of liver oncogenic potential among human RAS isoforms

Chung, S. I., Moon, H., Ju, H.-L., Kim, D. Y., Cho, K. J., Ribback, S., Dombrowski, F., Calvisi, D. F., & Ro, S. W. (2016) · Oncotarget · doi:10.18632/oncotarget.6931 · Cited by 13

TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma

Razzaque, M. S., & Atfi, A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.023 · Cited by 13

Novel KRAS Gene Mutations in Sporadic Colorectal Cancer

Naser, W. M., Shawarby, M. A., Al-Tamimi, D. M., Seth, A. K., Al-Quorain, A. A., Nemer, A. M. A., & Albagha, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113350 · Cited by 13

Acute sensitivity of the oral mucosa to oncogenic K‐ras

van der Weyden, L., Alcolea, M. P., Jones, P. H., Rust, A. G., Arends, M. J., & Adams, D. J. (2011) · The Journal of Pathology · doi:10.1002/path.2853 · Cited by 13

Role of PTPN11 (SHP2) in Cancer

Chan, G., & Neel, B. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_4 · Cited by 13

Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice

Sewastianik, T., Jiang, M., Sukhdeo, K., Patel, S. S., Roberts, K. G., Kang, Y., Alduaij, A., Dennis, P. S., Lawney, B. P., Liu, R., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017012211 · Cited by 13

Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras

Kawaguchi, Y., Hinoi, T., Saito, Y., Adachi, T., Miguchi, M., Niitsu, H., Sasada, T., Shimomura, M., Egi, H., Oka, S., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1121-9 · Cited by 13

Tumor suppressor p16INK4a controls oncogenic K‐Ras function in human pancreatic cancer cells

Rabien, A., Sanchez‐Ruderisch, H., Schulz, P. M., Otto, N., Wimmel, A., Wiedenmann, B., & Detjen, K. M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02140.x · Cited by 14

Using Genetically Engineered Mice for Radiation Research

Kirsch, D. G. (2011) · Radiation Research · doi:10.1667/rrxx35.1 · Cited by 13

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition

van Houdt, W. J., de Bruijn, M. T., Emmink, B. L., Raats, D., Hoogwater, F. J. H., Rinkes, I. H. M. B., & Kranenburg, O. (2010) · Analytical Cellular Pathology · doi:10.1155/2010/120143 · Cited by 13

MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept

Chaput, D., & Andelfinger, G. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.02.020 · Cited by 12

Mechanism of interaction of small transcription inhibitors with DNA in the context of chromatin and telomere

Ghosh, S., Majumder, P., Pradhan, S. K., & Dasgupta, D. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.06.008 · Cited by 12

Transcription Factor Eb Is Required for Macropinocytosis-Mediated Growth Recovery of Nutrient-Deprived Kras-Mutant Cells

Jeong, S., Byun, J., Cho, S. J., Chin, J., Lee, I., Choi, Y., & Park, K. (2018) · Nutrients · doi:10.3390/nu10111638 · Cited by 12

Modeling Normal and Disordered Human Hematopoiesis

Beer, P. A., & Eaves, C. J. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.09.002 · Cited by 15

Exploiting Mouse Models to Study Ras-Induced Cutaneous Squamous Cell Carcinoma

Lowry, W. E., Flores, A., & White, A. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.03.017 · Cited by 12

Atypical flat lesions derive from pancreatic acinar cells

von Figura, G., Fahrenkrog-Petersen, L., Hidalgo‐Sastre, A., Hartmann, D., Hüser, N., Schmid, R. M., Hebrok, M., Roy, N., & Esposito, I. (2017) · Pancreatology · doi:10.1016/j.pan.2017.04.014 · Cited by 12

The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer

Weng, C., Lin, Y., & Cheng, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091369 · Cited by 12

Conditional Mouse Models of Cancer

Vignjevic, D. M., Fré, S., Louvard, D., & Robine, S. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_11 · Cited by 12

KRAS G12D mutation in Brunner gland adenoma

Ortega, M., Sparks, J., Lichy, J. H., & Nava, V. E. (2023) · BMJ Case Reports · doi:10.1136/bcr-2022-252160 · Cited by 11

Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma

Marinović, S., Škrtić, A., Ivković, T. C., Poljak, M., & Kapitanović, S. (2021) · Human Cell · doi:10.1007/s13577-021-00576-2 · Cited by 11

Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome

Wang, Z., Sun, Y., Gao, B., Lu, Y., Fang, R., Gao, Y., Xiao, T., Liu, X.-Y., Pao, W. J., Zhao, Y., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.032 · Cited by 11

Identification of cancer driver genes using Sleeping Beauty transposon mutagenesis

Takeda, H., Jenkins, N. A., & Copeland, N. G. (2021) · Cancer Science · doi:10.1111/cas.14901 · Cited by 11

Loss of the Tumor Suppressor Pten Promotes Proliferation of Drosophila melanogaster Cells In Vitro and Gives Rise to Continuous Cell Lines

Justiniano, S. E., Mathew, A., Mitra, S., Manivannan, S., & Simcox, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031417 · Cited by 11

Current methods in mouse models of pancreatic cancer.

Mazur, P., Herner, A., Neff, F., & Siveke, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_9 · Cited by 11

Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma

Neidler, S., Kruspig, B., Hewit, K. D., Monteverde, T., Gyurászová, K., Braun, A., Clark, W. A., James, D. T., Hedley, A., Nieswandt, B., et al. (2019) · Cancers · doi:10.3390/cancers11050600 · Cited by 12

Barriers to Ras transformation

Ferbeyre, G. (2007) · Nature Cell Biology · doi:10.1038/ncb0507-483 · Cited by 11

N-ras oncogene–induced gene expression in human hematopoietic progenitor cells: Upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation

Shen, S., Passioura, T., Symonds, G. P., & Dolnikov, A. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.011 · Cited by 11

Mouse Models of Follicular and Papillary Thyroid Cancer Progression

Russo, M. A., Arciuch, V. G. A., & Cristofano, A. D. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00119 · Cited by 10

Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α

Lau, K. S., Schrier, S. B., Gierut, J. J., Lyons, J., Lauffenburger, D. A., & Haigis, K. M. (2013) · Integrative Biology · doi:10.1039/c3ib40062j · Cited by 10

Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation

Ikenoue, T., Terakado, Y., Zhu, C., Liu, X., Ohsugi, T., Matsubara, D., Fujii, T., Kakuta, S., Kubo, S., Shibata, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19769-1 · Cited by 10

Mini-review: Trophic interactions between cancer cells and primary afferent neurons

Hunt, P. J., Andújar, F. N., Silverman, D. A., & Amit, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135658 · Cited by 10

Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization

Tan, M., Li, H., & Sun, Y. (2015) · Neoplasia · doi:10.1016/j.neo.2014.11.008 · Cited by 10

The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis

Weekes, C. D., & Winn, R. A. (2011) · Cancers · doi:10.3390/cancers3033676 · Cited by 10

Stem Cell Gene Expression Changes Induced Specifically by Mutated K-ras

Luo, F., Hamoudi, R., Brooks, D. G., Patek, C. E., & Arends, M. J. (2007) · Gene Expression · doi:10.3727/105221607783417583 · Cited by 10

Making Young Tumors Old: A New Weapon Against Cancer?

Sage, J. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.33.pe25 · Cited by 9

KRAS4B oncogenic mutants promote non-small cell lung cancer progression via the interaction of deubiquitinase USP25 with RNF31

Yang, C., Li, H.-X., Gan, H., Shuai, X., Dong, C., Wang, W. J., Lin, D., & Zhong, B. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.01.015 · Cited by 9

Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer

Hibshman, P. S., Stalnecker, C. A., Klomp, J. A., Drizyte‐Miller, K., Klomp, J. E., Edwards, A. C., Pita, L. M., Hodge, R. G., Diehl, J. N., Mouery, R. D., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adu7145 · Cited by 9

Embryonic Expression of NrasG 12 D Leads to Embryonic Lethality and Cardiac Defects

You, X., Ryu, M., Cho, E., Sang, Y., Damnernsawad, A., Zhou, Y., Liu, Y., Zhang, J., & Lee, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633661 · Cited by 9

Amplification of mutant KRASG12D in a patient with advanced metastatic pancreatic adenocarcinoma detected by liquid biopsy: A case report

Pittella-Silva, F., Kimura, Y., Low, S., Nakamura, Y., & Motoya, M. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2334 · Cited by 9

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer

Cho, S. H., Yoon, S., Lee, K. H., Kim, S.-W., & Kim, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-99197-w · Cited by 9

Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate

Tao, C., Makrides, N., Chuang, J.-Z., Wu, Y., Brooks, S. E., Esko, J. D., Sung, C.-H., & Zhang, X. (2022) · Development · doi:10.1242/dev.200569 · Cited by 9

Cancer‐causing MAP2K1 mutation in a mosaic patient with cardio‐facio‐cutaneous syndrome and immunodeficiency

Захарова, В. В., Raykina, E., Mersiyanova, I., Деордиева, Е. А., Pershin, D., Vedmedskia, V., Rodina, Y. A., Kuzmenko, N. B., Maschan, M. A., & Shcherbina, A. (2022) · Human Mutation · doi:10.1002/humu.24463 · Cited by 9

Deconstructing cancer with precision genome editing

Johnson, G. A., Gould, S. I., & Rivera, F. J. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230984 · Cited by 11

Genetische Grundlagen seborrhoischer Keratosen und epidermaler Nävi

Hafner, C. M., Hafner, H., & Groesser, L. (2014) · Der Pathologe · doi:10.1007/s00292-014-1928-9 · Cited by 9

Myocardial KRASG12D expression does not cause cardiomyopathy in mice

Dalin, M. G., Zou, Z. V., Täng, M. S., Safari, R., Karlsson, C., & Bergö, M. O. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt260 · Cited by 9

Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context

Guerra, C. E., Mijimolle, N., Dhawahir, A., Dubus, P. R., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 577

Mouse Tissues that Undergo Neoplastic Progression after K-Ras Activation Are Distinguished by Nuclear Translocation of phospho-Erk1/2 and Robust Tumor Suppressor Responses

Parikh, N., Shuck, R. L., Nguyen, T., Herron, A. J., & Donehower, L. A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0089 · Cited by 21

Conditional Expression of K- ras in an Epithelial Compartment that Includes the Stem Cells Is Sufficient to Promote Squamous Cell Carcinogenesis

Vitale-Cross, L. A., Amornphimoltham, P., Fisher, G. H., Molinolo, A., & Gutkind, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2623 · Cited by 133

Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder

Braun, B. S., Tuveson, D. A., Kong, N., Le, D. T., Kogan, S. C., Rozmus, J., Le Beau, M. M., Jacks, T. E., & Shannon, K. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307203101 · Cited by 299

Activating the Expression of Human K-rasG12D Stimulates Oncogenic Transformation in Transgenic Goat Fetal

Gong, J., Wang, Z., Polejaeva, I., Salgia, R., Kao, C., Chen, T., Cells, F., Gong, J., Polejaeva, I. A., Salgia, R., et al. (2016)